Complete response in borderline resectable pancreatic cancer after modified FOLFIRINOX chemotherapy followed by surgical resection: a case report

Borderline resectable pancreatic cancer (BRPC) constitutes a challenging subset of cases that fall between clearly resectable and unresectable disease. Pancreatic cancer has a poor prognosis, with a 5-year survival rate of 4.2%. In patients who underwent surgical resection, the 5-year survival rate...

Full description

Bibliographic Details

Published in:	Kosin Medical Journal
Main Authors:	Seong Hyun Koh, Jung Wook Lee
Format:	Article
Language:	English
Published:	Kosin University College of Medicine 2025-06-01
Subjects:	antineoplastic agents case reports neoadjuvant therapy pancreatic neoplasms treatment outcome
Online Access:	http://www.kosinmedj.org/upload/pdf/kmj-24-158.pdf